BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24608647)

  • 1. [Brief commentary on guidelines for the management of atopic dermatitis 2012 -the point of drug treatment].
    Saeki H
    Arerugi; 2013 Dec; 62(12):1584-90. PubMed ID: 24608647
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atopic dermatitis in pregnancy].
    Teraki Y
    Arerugi; 2014 Feb; 63(2):147-54. PubMed ID: 24714179
    [No Abstract]   [Full Text] [Related]  

  • 3. [Guidelines for the management of atopic dermatitis 2006].
    Yamamoto S
    Arerugi; 2008 Nov; 57(11):1103-8. PubMed ID: 19052504
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of juvenile atopic dermatitis].
    Takehara K
    Arerugi; 2010 Dec; 59(12):1625-7. PubMed ID: 21212728
    [No Abstract]   [Full Text] [Related]  

  • 5. [Local treatment of atopic dermatitis with calcineurin inhibitors].
    Langeland T
    Tidsskr Nor Laegeforen; 2006 Jan; 126(3):321-2. PubMed ID: 16440040
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of atopic eczema with calcineurin inhibitors].
    Luger TA; Bieber T; Meurer M; Mrowietz U; Schwarz T; Simon J; Werfel T; Zuberbier T
    J Dtsch Dermatol Ges; 2005 May; 3(5):385-91. PubMed ID: 16372807
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months.
    Thaci D; Chambers C; Sidhu M; Dorsch B; Ehlken B; Fuchs S
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1040-6. PubMed ID: 20158589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Topical steroids and tacrolimus for the treatment of atopic dermatitis].
    Furue M
    Fukuoka Igaku Zasshi; 2006 Oct; 97(10):285-92. PubMed ID: 17176879
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety considerations in topical treatments for atopic dermatitis.
    Nicol NH
    Pediatr Nurs; 2011; 37(6):295-301; quiz 302. PubMed ID: 22256690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
    Kirsner RS; Heffernan MP; Antaya R
    Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus ointment: new preparation. Too many unknowns.
    Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial.
    Mandelin J; Remitz A; Virtanen H; Reitamo S
    Acta Derm Venereol; 2010 Mar; 90(2):170-4. PubMed ID: 20169301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
    Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
    J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC; Fleisher AB
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1% pimecrolimus cream for atopic dermatitis.
    Eichenfield LF; Lucky AW; Boguniewicz M; Langley RG; Cherill R; Marshall K
    Arch Dermatol; 2003 Oct; 139(10):1369-70; author reply 1370-1. PubMed ID: 14568846
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrolimus concentrations in blood during topical treatment of atopic dermatitis.
    Kawashima M; Nakagawa H; Ohtsuki M; Tamaki K; Ishibashi Y
    Lancet; 1996 Nov; 348(9036):1240-1. PubMed ID: 8898050
    [No Abstract]   [Full Text] [Related]  

  • 18. Significantly elevated systemic levels after occlusive application of topical tacrolimus in atopic dermatitis.
    Beyerler M; Schmid-Grendelmeier P; Hafner J
    Dermatology; 2006; 212(3):260-1. PubMed ID: 16549924
    [No Abstract]   [Full Text] [Related]  

  • 19. A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis.
    Bernard LA; Cunningham BB; Al-Suwaidan S; Friedlander SF; Eichenfield LF
    Arch Dermatol; 2003 Feb; 139(2):229-31. PubMed ID: 12588240
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic agents of today and the future for atopic dermatitis].
    Ikoma A
    Nihon Yakurigaku Zasshi; 2006 Dec; 128(6):411-5. PubMed ID: 17167215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.